These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23549862)

  • 1. FGF-23, vascular calcification, and cardiovascular diseases in chronic hemodialysis patients.
    Moldovan D; Moldovan I; Rusu C; Kacso I; Patiu IM; Gherman-Caprioara M
    Int Urol Nephrol; 2014 Jan; 46(1):121-8. PubMed ID: 23549862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients.
    Turan MN; Kircelli F; Yaprak M; Sisman AR; Gungor O; Bayraktaroglu S; Ozkahya M; Asci G; Floege J; Ok E
    Int Urol Nephrol; 2016 Apr; 48(4):609-17. PubMed ID: 26865177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of fibroblast growth factor-23 and cardiovascular calcification in end-stage kidney disease patients on regular hemodialysis.
    El Baz TZ; Khamis OA; Ahmed Gheith OA; Abd Ellateif SS; Abdallah AM; Abd El Aal HC
    Saudi J Kidney Dis Transpl; 2017; 28(1):51-60. PubMed ID: 28098103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis.
    Nishizawa Y; Hosoda Y; Horimoto A; Omae K; Ito K; Higuchi C; Sakura H; Nitta K; Ogawa T
    Heart Vessels; 2021 Mar; 36(3):414-423. PubMed ID: 33000285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis.
    Kojima F; Uchida K; Ogawa T; Tanaka Y; Nitta K
    Int Urol Nephrol; 2008; 40(4):1067-74. PubMed ID: 18791804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients.
    Balci M; Kirkpantur A; Gulbay M; Gurbuz OA
    Hemodial Int; 2010 Oct; 14(4):425-32. PubMed ID: 20955275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of serum FGF-23 as a cardiovascular marker in HD patients.
    Sany D; Elsawy AE; Aziz A; Elshahawy Y; Ahmed H; Aref H; El Rahman MA
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):44-52. PubMed ID: 24434381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between vascular calcification assessed by simple radiography and non-fatal cardiovascular events in hemodialysis patients.
    Petrauskiene V; Vaiciuniene R; Bumblyte IA; Kuzminskis V; Ziginskiene E; Grazulis S; Jonaitiene E
    Nephrol Ther; 2016 Dec; 12(7):503-507. PubMed ID: 27776971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
    Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
    Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcification of abdominal aorta in patients recently starting hemodialysis: A single-center experience from Egypt.
    Fayed A; Elnokeety MM; Attia K; Sharaf El Din UA
    Saudi J Kidney Dis Transpl; 2019; 30(4):819-824. PubMed ID: 31464238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular Calcification Progression Is an Independent Predictor of Mortality in Patients on Haemodialysis.
    Jean G; Mayor B; Deleaval P; Lorriaux C; Hurot JM; Bresson E; Chazot C
    Nephron; 2015; 130(3):169-74. PubMed ID: 26113315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients.
    Ulutas O; Taskapan MC; Dogan A; Baysal T; Taskapan H
    Int Urol Nephrol; 2018 Jan; 50(1):137-142. PubMed ID: 29134617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
    Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
    Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor-23 levels are associated with vascular calcifications in peritoneal dialysis patients.
    Asicioglu E; Kahveci A; Arikan H; Koc M; Tuglular S; Ozener CI
    Nephron Clin Pract; 2013; 124(1-2):89-93. PubMed ID: 24157489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients.
    Sugimoto H; Ogawa T; Iwabuchi Y; Otsuka K; Nitta K
    Int Urol Nephrol; 2014 Jan; 46(1):99-106. PubMed ID: 23355029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification.
    Fu X; Cui QQ; Ning JP; Fu SS; Liao XH
    Med Sci Monit; 2015 Nov; 21():3467-73. PubMed ID: 26558428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of coronary calcification in Indian hemodialysis patients.
    Jasani R; Hase N; Kumar R; Dedhia P; Jamale T; Bajpai D
    Saudi J Kidney Dis Transpl; 2018; 29(4):822-827. PubMed ID: 30152418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of abdominal aortic calcification estimated by plain radiography with outcomes in haemodialysis patients: A 6-year follow-up study.
    Zhu X; Cai H; Zhu M; Zhan Y; Che M; Lin X; Zhang W; Ni Z
    Nephrology (Carlton); 2020 Jul; 25(7):559-565. PubMed ID: 31424612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of fibroblast growth factor 23 in the development of cardiovascular diseases in patients with end-stage renal failure on programmed hemodialysis].
    Dzgoeva FU; Sopoev MY; Bestaeva TL; Khamitsaeva OV; Ktsoeva FA; Sageeva RO
    Ter Arkh; 2016; 88(12):51-56. PubMed ID: 28139560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Risk Factors Including Bone-Derived Biomarkers and Aortic Arch Calcification in Maintenance Hemodialysis Patients.
    Nitta K; Hanafusa N; Okazaki M; Komatsu M; Kawaguchi H; Tsuchiya K
    Kidney Blood Press Res; 2018; 43(5):1554-1562. PubMed ID: 30347400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.